Presentations & Publications

Presentation

Targeting frameshift mutations with a Listeria monocytogenes immunotherapy drives neoantigen-specific anti-tumor immunity in the MC38 and CT26 mouse tumor models

AACR 2018

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases & breaking Advaxis news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.